Biopharmaceutical Company
Appears in 1 story
Leading developer of DB-OTO gene therapy, seeking FDA approval
Children born profoundly deaf can now hear their parents' voices. A single injection of gene therapy into the inner ear has restored hearing in dozens of patients with genetic deafness, moving some forms of lifelong hearing loss from permanent disability into the treatable category. The effect is rapid—most patients recover hearing within weeks—and sustained over at least two years of follow-up.
Updated Jan 9
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
